Aktuelle Dermatologie 2012; 38(03): 95-96
DOI: 10.1055/s-0031-1291548
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Neue pathogenetische Aspekte beim Merkelzellkarzinom[*]

New Pathogenetic Aspects in Merkel Cell Carcinoma
K. Krasagakis
Dermatologische Abteilung, Universitätskrankenhaus Heraklion, Kreta, Griechenland
› Author Affiliations
Further Information

Publication History

Publication Date:
13 January 2012 (online)

Zusammenfassung

Die jüngsten Entwicklungen zur Pathogenese des Merkelzellkarzinoms haben unser Verständnis für diesen Tumor beträchtlich verbessert. Die klonale Integration des Merkelzell(polyom)virus ins Genom der Tumorzellen und die tumorspezifische verkürzende Mutation des LT-Antigens während der Integration ist dabei der wesentliche Mechanismus, der zur Entartung der Zellen führt. Weitere Ereignisse tragen offensichtlich zur Merkelzelltransformation bei, wie die simultane Expression des Stammzellfaktors und seines Rezeptors KIT, was eine autokrine Förderung des Zellwachstums bewirkt.

Abstract

Recent developments on Merkel cell carcinoma pathogenesis have substantially improved our understanding for this tumor. The clonal integration of the Merkel cell (polyoma) virus in the genome of the tumor cells and the tumor specific truncating mutation of the LT antigen during integration represent a major mechanism for carcinogenesis. Additional events apparently contribute to Merkel cell transformation, such as the simultaneous expression of stem cell factor and his receptor KIT resulting in an autocrine stimulation of cell growth.

* Nach einem Vortrag anlässlich des 11. Jahressymposions der Berliner Stiftung für Dermatologie am 2. Juli 2011, Berlin.


 
  • Literatur

  • 1 Andea AA, Patel R, Ponnazhagan S et al. Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status. Hum Pathol 2010; 41: 1405-1412
  • 2 Feng H, Shuda M, Chang Y et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100
  • 3 Shuda M, Feng H, Kwun HJ et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008; 105: 16272-16277
  • 4 Krasagakis K, Krüger-Krasagakis S, Eberle J et al. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma. Dermatology 2009; 218: 37-43
  • 5 Krasagakis K, Metaxari M, Zervou M et al. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma. Anticancer Res 2011; a 31: 807-811
  • 6 Krasagakis K, Fragiadaki I, Metaxari M et al. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of Merkel cell carcinoma in vitro. J Cell Physiol 2011; b 226: 1099-1109
  • 7 Pastrana DV, Tolstov YL, Becker JC et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5: e1000578
  • 8 Tolstov YL, Pastrana DV, Feng H et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125: 1250-1256